Target Audience follow are: Pharmaceutical and biotechnology companies, Life sciences instrumentation and reagents companies, High-content screening database and software providers, High-content screening service providers, Business research and consulting firms, Academic institutes and government organizations.
High content screening (HCS) market report review 2017-2022 of 166 pages added by reports and reports explores global High content screening (HCS) market product, system, technology, database, current trends and shares, analysis, techniques, growth, opportunity, application, end user, and region and key company analysis to 2022. Report provides High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, and Service) Application (Primary & Secondary Screening, Toxicity Studies, and Target Identification & Validation).
The global high content screening (HCS) market is projected to reach USD 909.0 million by 2022, high content screening (HCS) market at a CAGR of 10.3% during the forecast period.
To know about the assumptions considered for the High content screening (HCS) market study sample copy here@ www.reportsnreports.com/contacts/r…aspx?name=274849
North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major pharmaceutical market players, and increasing government support are some of the factors contributing to the large share of North America in the market.
However, the Asia-Pacific market is expected to register the highest growth during the forecast period owing to increased research in drug discovery, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure
The factors expected to drive the growth of the market are cost containment in pharmaceutical R&D, increasing funding for cellular research, and technological advancements in HCS solutions during the forecast period. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market.
However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth to a certain extent. Report on High content screening (HCS) market 2017-2022 spreads across 166 pages profiling 11 companies and supported with 138 tables and 42 figures available at www.reportsnreports.com/contacts/d…aspx?name=274849
The major players in the market are GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).
Key Target Audience of this research report are
- Pharmaceutical and biotechnology companies
- Life sciences instrumentation and reagents companies
- High-content screening database and software providers
- High-content screening service providers
- Business research and consulting firms
- Academic institutes and government organizations
- Clinical research organizations (CRO)
- Government bodies
Get direct order to complete report copy for single/corporate users here @ www.reportsnreports.com/purchase.aspx?name=274849
The report provides an insight on the HCS product matrix which presents comparative analysis of product portfolios of leading market players. Moreover, the vendor benchmarking provided in the report illustrates the comparison between the geographic and product strength of top companies.
Based on application, the market is segmented into target identification and validation, primary and secondary screening, toxicity studies, compound profiling, and other applications such as angiogenesis, apoptosis, cell cycle and mitotic index, cell proliferation, endocytosis, protein synthesis, and stem cell differentiation..
Based on end user, the market is segmented into pharmaceutical & biotechnology companies, academic & government institutes, and contract research organizations.
Fundamental from Table of Content
7 Global High-Content Screening Market, By Product
7.2.1 Cell Imaging and Analysis Systems
7.2.2 Flow Cytometers
18.104.22.168 Cell Analyzers
22.214.171.124 Cell Sorters
7.3.1 Reagents & Assay Kits
7.3.3 Other Consumables
8 Global High-Content Screening Market, By Application
8.2 Primary and Secondary Screening
8.3 Target Identification and Validation
8.4 Toxicity Studies
8.5 Compound Profiling
8.6 Other Applications
9 Global High-Content Screening Market, By End User
9.2 Pharmaceutical and Biotechnology Companies
9.3 Academic and Government Institutes
9.4 Contract Research Organizations